SH3RF2
Gene Information
- Official Symbol: SH3RF2
- Official Name: SH3 domain containing ring finger 2
- Aliases and Previous Symbols: N/A
- Entrez ID: 153769
- UniProt: Q8TEC5
- Interactions: BioGRID
- PubMed articles: Open PubMed
- OMIM: Open OMIM
Function Summary
- Entrez Summary: N/A
- UniProt Summary: Inhibits PPP1CA phosphatase activity. May be a E3 ubiquitin-protein ligase (Potential). May play a role in cardiac function. {ECO:0000269|PubMed:19389623, ECO:0000269|PubMed:19945436, ECO:0000305}.
Pfam Domains GO Terms
Pfam Domains
| SH3 1 |
| SH3 2 |
| zf-C3HC4 |
GO Terms
| protein phosphatase 1 binding |
| protein phosphatase inhibitor activity |
| negative regulation of JNK cascade |
| negative regulation of stress-activated protein kinase signaling cascade |
| negative regulation of stress-activated MAPK cascade |
| phosphatase binding |
| negative regulation of phosphoprotein phosphatase activity |
| protein autoubiquitination |
| negative regulation of protein dephosphorylation |
| negative regulation of protein ubiquitination |
| positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
| negative regulation of protein modification by small protein conjugation or removal |
| positive regulation of ubiquitin-dependent protein catabolic process |
| positive regulation of proteasomal protein catabolic process |
| negative regulation of phosphatase activity |
| negative regulation of dephosphorylation |
| regulation of phosphoprotein phosphatase activity |
| positive regulation of proteolysis involved in cellular protein catabolic process |
| regulation of proteasomal ubiquitin-dependent protein catabolic process |
| positive regulation of JNK cascade |
| regulation of protein dephosphorylation |
| positive regulation of cellular protein catabolic process |
| regulation of ubiquitin-dependent protein catabolic process |
| positive regulation of stress-activated MAPK cascade |
| negative regulation of MAPK cascade |
| positive regulation of stress-activated protein kinase signaling cascade |
| regulation of phosphatase activity |
| regulation of proteasomal protein catabolic process |
| regulation of JNK cascade |
| regulation of protein ubiquitination |
| regulation of dephosphorylation |
| positive regulation of protein catabolic process |
| regulation of proteolysis involved in cellular protein catabolic process |
| ubiquitin protein ligase activity |
| regulation of protein modification by small protein conjugation or removal |
| regulation of stress-activated MAPK cascade |
| regulation of stress-activated protein kinase signaling cascade |
| regulation of cellular protein catabolic process |
| positive regulation of proteolysis |
| positive regulation of cellular catabolic process |
| regulation of protein catabolic process |
| negative regulation of protein phosphorylation |
| positive regulation of catabolic process |
| negative regulation of phosphorylation |
| negative regulation of hydrolase activity |
| positive regulation of cell migration |
| negative regulation of intracellular signal transduction |
| positive regulation of cell motility |
| positive regulation of cellular component movement |
| positive regulation of MAPK cascade |
| positive regulation of locomotion |
| negative regulation of phosphate metabolic process |
| negative regulation of phosphorus metabolic process |
| negative regulation of protein modification process |
| protein ubiquitination |
| regulation of proteolysis |
| regulation of cellular response to stress |
| regulation of MAPK cascade |
| protein modification by small protein conjugation |
| negative regulation of catalytic activity |
| regulation of cellular catabolic process |
| regulation of cell migration |
| negative regulation of apoptotic process |
| negative regulation of programmed cell death |
| regulation of cell motility |
| regulation of locomotion |
| protein modification by small protein conjugation or removal |
| regulation of cellular component movement |
| regulation of catabolic process |
| negative regulation of cell death |
| positive regulation of protein phosphorylation |
| positive regulation of intracellular signal transduction |
| negative regulation of cellular protein metabolic process |
| positive regulation of phosphorylation |
| negative regulation of protein metabolic process |
| positive regulation of phosphate metabolic process |
| positive regulation of phosphorus metabolic process |
| negative regulation of molecular function |
| positive regulation of protein modification process |
| negative regulation of signal transduction |
| regulation of hydrolase activity |
| negative regulation of cell communication |
| negative regulation of signaling |
| regulation of protein phosphorylation |
| regulation of response to stress |
| regulation of apoptotic process |
| regulation of programmed cell death |
| regulation of phosphorylation |
| positive regulation of cellular protein metabolic process |
| negative regulation of response to stimulus |
| positive regulation of signal transduction |
| regulation of cell death |
| positive regulation of protein metabolic process |
| regulation of phosphate metabolic process |
| regulation of phosphorus metabolic process |
| positive regulation of cell communication |
| positive regulation of signaling |
| regulation of intracellular signal transduction |
| regulation of protein modification process |
CRISPR Data
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Compound Hit
| Screen | Score |
|---|---|
| R-DABN 8μM R03 exp111 | -1.92 |
| Q15 1 to 2μM on day4 R04 exp164 | -1.77 |
| Vinblastine 0.015μM R05 exp208 | -1.73 |
Most Correlated Genes in Chemogenomics
No correlation found to any other genes in chemogenomics.
Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Global Fraction of Cell Lines Where Essential: 0/739
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Essentiality in NALM6
- Essentiality Rank: 13678
- Expression level (log2 read counts): 0.65
Expression Distribution
SH3RF2 Expression in NALM6 Cells: 0.65